GABANO, Elisabetta
 Distribuzione geografica
Continente #
EU - Europa 3.125
NA - Nord America 2.947
AS - Asia 787
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
SA - Sud America 5
Totale 6.877
Nazione #
US - Stati Uniti d'America 2.896
IE - Irlanda 1.082
DE - Germania 544
SE - Svezia 527
UA - Ucraina 396
HK - Hong Kong 259
IT - Italia 251
CN - Cina 248
FI - Finlandia 239
SG - Singapore 129
IN - India 100
CA - Canada 51
IR - Iran 36
GB - Regno Unito 28
BE - Belgio 18
TR - Turchia 11
FR - Francia 9
RU - Federazione Russa 9
EU - Europa 8
RO - Romania 8
NL - Olanda 5
EG - Egitto 4
VN - Vietnam 4
BR - Brasile 3
AL - Albania 2
AT - Austria 2
HR - Croazia 2
UY - Uruguay 2
ES - Italia 1
PL - Polonia 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 6.877
Città #
Dublin 1.075
Jacksonville 746
Dearborn 412
Hong Kong 259
Chandler 217
Wilmington 186
Ann Arbor 146
Lawrence 134
Princeton 134
Beijing 105
Piemonte 104
San Mateo 90
Andover 84
Singapore 74
Ashburn 57
Bremen 50
Grafing 49
Toronto 42
Leawood 21
Cave Creek 19
Hefei 19
Helsinki 18
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Nanjing 17
Brussels 16
Boardman 15
Kunming 15
Norwalk 15
Kocaeli 11
Guangzhou 10
Munich 10
Ardabil 9
Fairfield 9
Jinan 9
Augusta 8
Hebei 8
Houston 7
Udine 7
Wuhan 7
Mülheim 6
Sacramento 6
Shenyang 6
Winnipeg 6
Como 5
Fuzhou 5
Gunzenhausen 5
Ronco 5
Turin 5
Dong Ket 4
Menlo Park 4
Novara 4
Trieste 4
Villar Focchiardo 4
Asti 3
Bulandshahr 3
Cairo 3
Cambridge 3
Chengdu 3
Lucca 3
Milan 3
Moscow 3
Ningbo 3
Padova 3
Quzhou 3
Rome 3
Zhengzhou 3
Bari 2
Biella 2
Borgomanero 2
Changchun 2
Chaoyang 2
Des Moines 2
Düsseldorf 2
Giaveno 2
Hayward 2
Henderson 2
Huskvarna 2
Innsbruck 2
Lerici 2
London 2
Montevideo 2
Nanchang 2
New York 2
Rio de Janeiro 2
Seattle 2
Sherbrooke 2
Simi Valley 2
Taizhou 2
Torino 2
Volpedo 2
Waanrode 2
Wenzhou 2
Xian 2
Zagreb 2
Alba 1
Bangalore 1
Baotou 1
Bellinzago Novarese 1
Totale 4.436
Nome #
Transition metal carbonyl clusters in biology: A futile or niche research area? 97
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 90
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 87
Different strategies to exploit Pt(IV) complexes as pro-drugs 86
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 85
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 82
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 79
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 77
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 77
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 74
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 73
195Pt NMR chemical shift: a chemometric approach 72
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 70
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 70
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 70
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 69
A different way for the oxidation of the Pt(II) complexes 69
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 68
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 68
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 68
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 67
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 65
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 65
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 65
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 64
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 63
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 63
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 63
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 63
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 62
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 62
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 62
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 61
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 61
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 61
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 60
Pt(IV) complexes as anticancer prodrugs 60
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 60
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 60
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 58
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 58
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 58
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 57
Pt-195 NMR spectroscopy: A chemometric approach 57
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 57
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 57
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 56
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 56
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 56
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 55
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 55
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 54
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 54
A view on multi-action Pt(IV) antitumor prodrugs 54
Experimental determination and modeling of the lipophilicity in platinum complexes 53
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 52
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 51
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 51
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 50
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 50
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 50
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 50
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 49
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 49
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 49
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 49
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 48
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 48
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 47
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 46
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs 46
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 46
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 45
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 45
Study of methylation of carrier ligands in cis-[APtCl2] (A = substituted ethylenediamine) complexes 44
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 44
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 44
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases 44
Synthesis And Characterization of Estradiol Derived Platinum Complexes 43
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 43
log Po/w determination for a series of Pt(II) complexes by means of reverse phase HPLC 43
Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules 43
Trend in cytotoxic activity of a series of cis-[APtCl(2)] (A = ethylenediamine methylated at different positions) complexes 43
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 43
Platinum(II) and technetium(I) complexes anchored to ethynylestradiol: a way to drug targeting and delivery 43
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 43
Ethynylestradiol-Pt(II) complexes for selective drug targeting 42
Relationship Among Potency (IC50), Reduction Potential (E°’) And Partition Coefficient (log Po/w) Of New Antitumour Pt(IV) Complexes 42
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 42
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 42
Stepwise Assembly of Platinum-Folic Acid Conjugates 42
The RP-HPLC measurement and QSPR analysis of log Po/w values of several Pt(II) complexes 42
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 42
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 42
Estradiol Derivatives as Carrier For Selective Vehiculation of Cytotoxic Pt(II) Complexes Towards Cancer Cells 41
The drug targeting and delivery approach applied to Pt-antitumour complexes. A coordination point of view 41
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 41
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 40
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 40
Platinum(II) complexes with pyrazolyl-diamine chelators bearing DNA-binding groups”, 39
Totale 5.632
Categoria #
all - tutte 35.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.466 6 9 131 15 237 249 324 72 156 123 138 6
2020/2021914 132 7 135 9 106 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 7.044